​Established in 2017
NanoBio Designs was founded to commercialize parent company DNP123 Co.'s nanotechnology methods able to provide a clear visible distinction between samples with and without target DNA sequences.  It is 95% owned by DNP123 Co. and 5% by The Emerge Foundation, hosted at Simpson College, as it validates commercial viability and scale.  Investment opportunities are scheduled starting in late 2019 as this occurs.

Corteva Radical Growth Challenge Finalist

2020

Our Goals

1. Validate protocols and add to accuracy data sets.
2. Complete initial paid pilot projects and device 3.0 component sourcing.
3. Develop novel use cases for particle assembly technologies.
4. Finalize paths to initial target markets.
5. Ramp up platform sales; transition from pilot projects.

Meet Our Team

Derek Lyons, Ph.D​
​Board Chair | Platform CTO

Ph.D., University of Michigan
B.A in Chemistry, Simpson College
Studied the structure and function of DNA repair mechanisms

Ryan Skaar, MS
COO

M.S. in Pharmaceutical Chemistry,  KU
B.A in Biochemistry, Simpson College
Trained in leadership, communication, and entrepreneurship as a Madison and Lila SELF Graduate Fellow.

Todd Kielkopf, MS
CEO

M.S. in Business Administration, ISU
B.A in Finance, University of Northern Iowa
25+ years of business and financial leadership and business development strategy consulting

Aaron Santos, Ph.D
Board Member

Ph.D., Boston University
B.A in Physics, MIT
Research expertise in microparticle and DNA kinetics

Karl Wilt, MA
Contract CFO

CustomeOne CFO & Controllers
M.S. in Accounting, Depaul University
B.A. in Economics, University of Chicago
​25+ years of CFO experience and related consulting

Rich Stevens, PE
Engineering Advisor

Stevens Product Development
Iowa-licensed P.E. with B.S. degree in Mechanical Engineering from ISU
​20+ years experience designing technical devices and prototypes